PAYO:NASDAQPayoneer Global Inc. Analysis
Data as of 2026-04-23 - not real-time
$4.90
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Payoneer (PAYO) trades around $4.90, just above its 20‑day SMA of $4.93 and 50‑day SMA of $4.89, indicating a tight price corridor. RSI sits near 48, suggesting neither overbought nor oversold conditions, while the MACD histogram is positive and the signal line is bullish, hinting at modest upward momentum. The stock’s beta of 1.67 and 30‑day volatility of 45% signal a high‑risk profile relative to the market. Fundamentally, PAYO’s trailing P/E of 25.8 is well below the industry average of 37, and the forward P/E of 14.5 reflects accelerating earnings expectations. Revenue grew 5% YoY to $1.05 bn with an impressive 84% gross margin and a 12.5% operating margin, supporting a solid profitability base. Cash is strong at $416 m versus $72 m of debt, yielding a low debt‑to‑equity of 10%, though free cash flow is slightly negative. The DCF‑derived fair value of $8.91 implies a 53% upside from current levels, and analyst consensus rates the stock a “strong buy.” Upcoming Q1 2026 earnings on May 7 could serve as a catalyst, but decreasing volume and a neutral trend caution against aggressive short‑term moves. Overall, the blend of undervaluation, solid margins, and growth potential positions PAYO as an attractive medium‑ to long‑term play, albeit with heightened market and regulatory risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term support with decreasing volume
- Bullish MACD but neutral overall trend
- High beta and volatility increase short‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value suggests >50% upside
- Strong margins and low debt support earnings growth
- Upcoming earnings release may unlock valuation
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable revenue growth in a global fintech market
- Undervalued relative to peers and industry P/E
- Diversified geographic exposure offsets some regulatory risk
Key Metrics & Analysis
Financial Health
Revenue Growth4.90%
Profit Margin6.95%
P/E Ratio25.8
ROE10.24%
ROA1.00%
Debt/Equity10.27
P/B Ratio2.4
Op. Cash Flow$233.5M
Free Cash Flow$-14377375
Industry P/E37.0
Technical Analysis
TrendNeutral
RSI48.1
Support$4.38
Resistance$5.35
MA 20$4.93
MA 50$4.89
MA 200$5.83
MACDBullish
VolumeDecreasing
Fear & Greed Index86.71
Valuation
Fair Value$8.91
Target Price$7.50
Upside/Downside53.22%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.67
Volatility45.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.